Principal Investigator
Patrick VERMERSCH, MD, PhD
University of Lille, CHU of Lille, France
- 2 trials
- 1 compound
Therapeutic focus
- Progressive Multiple Sclerosis
- Multiple Sclerosis, Secondary Progressive
- Multiple Sclerosis, Primary Progressive
- Multiple Sclerosis, Relapse Free
All trials (2)
| NCT | Phase | Status | Compound | Sponsor |
|---|---|---|---|---|
| NCT05441488 | Phase 3 | Discontinued | Masitinib | AB Science |
| NCT01433497 | Phase 3 | Completed | Masitinib | AB Science |
Compounds studied
Trial sites (38)
- Gothenburg, Sweden
- Bilbao, Spain
- Saint Petersburg, Russia
- Katowice, Poland
- Poissy, France
- Valencia, Spain
- Créteil, France
- Lublin, Poland
- Sofia, Bulgaria
- Vinnytsia, Ukraine
- Nice, France
- Strasbourg, France
- Rivne, Ukraine
- Volos, Greece
- Thessaloniki, Greece
- Warsaw, Poland
- Perm, Russia
- Madrid, Spain
- Oświęcim, Poland
- Poznan, Poland
- Ksawerów, Poland
- Ternopil, Ukraine
- Athens, Greece
- Marburg, Germany
- Poitiers, France
- Rouen, France
- Lodz, Poland
- Montpellier, France
- Larissa, Greece
- Nîmes, France
- Lille, France
- Catania, Italy
- Moscow, Russia
- Barcelona, Spain
- Stockholm, Sweden
- Campulung Muscel, Romania
- Toulouse, France
- Lviv, Ukraine
Investigator and site data mirrored fromClinicalTrials.gov (public domain).